Overview
Brucellosis, also known as undulant fever, Malta fever, or Mediterranean fever, is a zoonotic infectious disease caused by bacteria of the genus Brucella. The most common species affecting humans include Brucella melitensis (from goats and sheep), Brucella abortus (from cattle), Brucella suis (from pigs), and Brucella canis (from dogs). Humans typically acquire the infection through consumption of unpasteurized dairy products, direct contact with infected animals or their secretions, or inhalation of contaminated aerosols. The disease is considered rare in developed countries but remains endemic in parts of the Mediterranean, Middle East, Central Asia, and Latin America. Brucellosis is a systemic infection that can affect virtually any organ system. The bacteria invade the reticuloendothelial system, affecting the liver, spleen, bone marrow, and lymph nodes. Key clinical features include undulating (wave-like) fever, profuse sweating (often with a characteristic odor), fatigue, malaise, joint and muscle pain, headache, and weight loss. Hepatosplenomegaly (enlargement of the liver and spleen) is common. Complications can involve the musculoskeletal system (sacroiliitis, spondylitis, arthritis), cardiovascular system (endocarditis, which is the leading cause of brucellosis-related mortality), central nervous system (neurobrucellosis with meningitis or encephalitis), and genitourinary system (epididymo-orchitis). The disease can follow an acute, subacute, or chronic course, and relapse is common if inadequately treated. Treatment of brucellosis requires prolonged combination antibiotic therapy. The World Health Organization recommends doxycycline combined with streptomycin or rifampicin for a minimum of six weeks. For complicated cases such as neurobrucellosis or endocarditis, treatment duration is extended and may include additional agents such as trimethoprim-sulfamethoxazole or ceftriaxone. Early diagnosis and appropriate treatment generally lead to a good prognosis, though chronic forms and relapses can occur. There is no widely available human vaccine, and prevention relies on animal vaccination programs, pasteurization of dairy products, and occupational safety measures for those working with livestock.
Clinical phenotype terms— hover any for plain English:
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsUniversity Hospital, Montpellier — NA
Assistance Publique - Hôpitaux de Paris — PHASE3
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Brucellosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Brucellosis at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Brucellosis.
Community
No community posts yet. Be the first to share your experience with Brucellosis.
Start the conversation →Latest news about Brucellosis
Disease timeline:
New recruiting trial: Outcomes of Inspiratory Muscle Training in FMF Adolescents
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Real World Study of Classic Infectious Disease
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy
A new clinical trial is recruiting patients for Brucellosis
New recruiting trial: Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
A new clinical trial is recruiting patients for Brucellosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Brucellosis
What is Brucellosis?
Brucellosis, also known as undulant fever, Malta fever, or Mediterranean fever, is a zoonotic infectious disease caused by bacteria of the genus Brucella. The most common species affecting humans include Brucella melitensis (from goats and sheep), Brucella abortus (from cattle), Brucella suis (from pigs), and Brucella canis (from dogs). Humans typically acquire the infection through consumption of unpasteurized dairy products, direct contact with infected animals or their secretions, or inhalation of contaminated aerosols. The disease is considered rare in developed countries but remains endem
Which specialists treat Brucellosis?
25 specialists and care centers treating Brucellosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.